Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-19

FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application to add the intravenous form of Protonix (pantoprazole sodium) to Wyeth/Pfizer's product line, expanding its use for pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROTONIX I.V. (pantoprazole sodium)

Snippet

SUPPL AP for PROTONIX I.V. (PANTOPRAZOLE SODIUM)